IPIX (Innovation Pharmaceuticals) Beginning Cash Position: $1.52 Mil (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Innovation Pharmaceuticals Beginning Cash Position?

Innovation Pharmaceuticals IPIX Beginning Cash Position is $1.52 Mil as of Sep. 2023.

Innovation Pharmaceuticals's Beginning Cash Position for the quarter that ended in Sep. 2023 was $1.52 Mil.

Innovation Pharmaceuticals's quarterly Beginning Cash Position declined from Mar. 2023 ($2.42 Mil) to Jun. 2023 ($1.94 Mil) and declined from Jun. 2023 ($1.94 Mil) to Sep. 2023 ($1.52 Mil).

Innovation Pharmaceuticals's annual Beginning Cash Position increased from Jun. 2021 ($6.02 Mil) to Jun. 2022 ($10.19 Mil) but then declined from Jun. 2022 ($10.19 Mil) to Jun. 2023 ($3.81 Mil).

Innovation Pharmaceuticals Beginning Cash Position Related Terms

Innovation Pharmaceuticals Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Innovation Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation Pharmaceuticals Beginning Cash Position Chart

Innovation Pharmaceuticals Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.42 0.58 6.02 10.19 3.81

Innovation Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.81 2.97 2.42 1.94 1.52

Innovation Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $1.52 Mil mean?
Innovation Pharmaceuticals (IPIX) has a Beginning Cash Position of $1.52 Mil as of Sep. 2023. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Innovation Pharmaceuticals and its competitors.
Is Innovation Pharmaceuticals' Beginning Cash Position too high?
Innovation Pharmaceuticals' current Beginning Cash Position is $1.52 Mil.
How does Innovation Pharmaceuticals' Beginning Cash Position compare to AXIM and RNAZ?
Innovation Pharmaceuticals' Beginning Cash Position of $1.52 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Innovation Pharmaceuticals and its competitors. Innovation Pharmaceuticals's current Beginning Cash Position is $1.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovation Pharmaceuticals stock overvalued right now?
Innovation Pharmaceuticals (IPIX) has a current Beginning Cash Position of $1.52 Mil. The current Beginning Cash Position is $1.52 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Innovation Pharmaceuticals (IPIX), the current Beginning Cash Position is $1.52 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation Pharmaceuticals Business Description

Address 301 Edgewater Place, Suite 100, Wakefield, MA, USA, 01880
Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, and inflammatory disease.